LEBANON N.J. Sept. 21 2017 PRNewswire Provention Bio Inc. a clinical stage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at intercepting and preventing immunemediated diseases announced today that ...
↧
Provention Bio Announces Licensing Agreements with Janssen for Two ClinicalStage Immunology Assets
↧